HLHaojun Luo

Haojun Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haojun Luo has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Manran Liu

    Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China

    13 shared publications
  • Rui Tang

    Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China

    10 shared publications
  • Yan Sun

    Department of Nephrology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

    10 shared publications
  • Ming Xu

    Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China

    9 shared publications
  • Rui Wang

    Chongqing Medical University 2 Key Laboratory of Clinical Laboratory Medical Diagnostics, Chinese Ministry of Education Chongqing, China

    9 shared publications
  • Ting Jin

    Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China

    9 shared publications

Latest Publications

  • Open Access

    Unfolded protein response kinase PERK supports survival and metastasis of circulating tumor cell clusters via SAM synthesis and H3K4me3‐dependent PDGFB signaling

    by Rui Tang, Yan Sun, Ao Deng, Jiahe Liu, Peijin Dai, Jing Chen, Chaoqun Deng, Hui Liu, Yuhang Hai, Yanran Tong, et al.

    Background: Metastasis is the leading cause of cancer‐related mortality, with circulating tumor cell (CTC) clusters serving as highly efficient precursors of distant metastasis. Survival of CTC clusters in the bloodstream is the primary contributor to tumor metastasis. However, the underlying mechanisms of how CTC clusters respond to the blood environment and drive metastasis remain elusive. This study aimed to elucidate the potential mechanisms that enable CTC clusters to adapt and survive in the bloodstream. Methods: CTC clusters were detected using a microfluidic system in cancer patients, as well as in patient‐derived xenograft (PDX), cell line‐derived xenograft, and syngeneic models. The key molecules responsible for the adaptive survival of CTC clusters were characterized using RNA‐sequencing (RNA‐seq), gene interference, and flow cytometry. To investigate the underlying mechanisms of adaptive survival, RNA‐seq, targeted metabolomics, isotope tracing experiments, chromatin immunoprecipitation (ChIP) sequencing, and immunofluorescence (IF) staining were employed. The therapeutic potential of survival pathway inhibitor combined with chemotherapy drug was evaluated in patient‐derived CTCs and the PDX model. Results: CTC clusters exhibited superior survival and metastatic capacity compared to single CTCs and were associated with adverse clinical outcomes. The unfolded protein response mediator protein kinase R‐like endoplasmic reticulum kinase (PERK) was activated in CTC clusters and maintained S‐adenosylmethionine (SAM) availability, facilitating their adaptive survival in the bloodstream. Mechanistically, PERK mediated the upregulation of activating transcription factor 4 (ATF4), which enhanced methionine adenosyltransferase 2A (MAT2A) expression, contributing to SAM synthesis. Increased SAM enhanced H3K4me3 modification of the platelet‐derived growth factor B ( PDGFB ) promoter, leading to elevated PDGFB secretion and its accumulation in the intercellular region within CTC clusters. PDGFB functioned as a shared survival signal, triggering the phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) pathway via platelet‐derived growth factor receptor beta (PDGFRβ), supporting CTC cluster survival in the bloodstream. Inhibition of PERK and PDGFRβ profoundly impaired the survival signaling and suppressed the metastatic dissemination of CTC clusters. Conclusions: Our findings revealed a PERK/MAT2A/PDGFB axis that confers adaptive survival capabilities to CTC clusters in the bloodstream. Targeting this survival signaling pathway represents a promising therapeutic strategy for metastatic cancer.


  • Open Access

    Large Language Models as a Consulting Hotline for Patients With Breast Cancer and Specialists in China: Cross-Sectional Questionnaire Study

    by Hui Liu, Jialun Peng, Lu Li, Ao Deng, XiangXin Huang, Guobing Yin, Haojun Luo

    Background: The disease burden of breast cancer is increasing in China. Guiding people to obtain accurate information on breast cancer and improving the public’s health literacy are crucial for the early detection and timely treatment of breast cancer. Large language model (LLM) is a currently popular source of health information. However, the accuracy and practicality of the breast cancer–related information provided by LLMs have not yet been evaluated. Objective: This study aims to evaluate and compare the accuracy, practicality, and generalization-specificity of responses to breast cancer–related questions from two LLMs, ChatGPT and ERNIE Bot (EB). Methods: The questions asked to the LLMs consisted of a patient questionnaire and an expert questionnaire, each containing 15 questions. ChatGPT was queried in both Chinese and English, recorded as ChatGPT-Chinese (ChatGPT-C) and ChatGPT-English (ChatGPT-E) respectively, while EB was queried in Chinese. The accuracy, practicality, and generalization-specificity of each inquiry’s responses were rated by a breast cancer multidisciplinary treatment team using Likert scales. Results: Overall, for both the patient and expert questionnaire, the accuracy and practicality of responses from ChatGPT-E were significantly higher than those from ChatGPT-C and EB (all Ps<.001). However, the responses from all LLMs are relatively generalized, leading to lower accuracy and practicality for the expert questionnaire compared to the patient questionnaire. Additionally, there were issues such as the lack of supporting evidence and potential ethical risks in the responses of LLMs. Conclusions: Currently, compared to other LLMs, ChatGPT-E has demonstrated greater potential for application in educating Chinese patients with breast cancer, and may serve as an effective tool for them to obtain health information. However, for breast cancer specialists, these LLMs are not yet suitable for assisting in clinical diagnosis or treatment activities. Additionally, data security, ethical, and legal risks associated with using LLMs in clinical practice cannot be ignored. In the future, further research is needed to determine the true efficacy of LLMs in clinical scenarios related to breast cancer in China.


  • Open Access

    Circulating Tumor Microenvironment in Metastasis

    by Rui Tang, Shujuan Luo, Hui Liu, Yan Sun, Manran Liu, Lu Li, Haoyu Ren, Martin K. Angele, Nikolaus Börner, Keda Yu, et al.

    Activation of invasion and metastasis is a central hallmark of cancer, contributing to the primary cause of death for patients with cancer. In the multistep metastatic process, cancer cells must infiltrate the circulation, survive, arrest at capillary beds, extravasate, and form metastatic clones in distant organs. However, only a small proportion of circulating tumor cells (CTC) successfully form metastases, with transit of CTCs in the circulation being the rate-limiting step. The fate of CTCs is influenced by the circulating tumor microenvironment (cTME), which encompasses factors affecting their biological behaviors in the circulation. This liquid and flowing microenvironment differs significantly from the primary TME or the premetastatic niche. This review summarizes the latest advancements in identifying the biophysical cues, key components, and biological roles of the cTME, highlighting the network among biophysical attributes, blood cells, and nonblood factors in cancer metastasis. In addition to the potential of the cTME as a therapeutic target for inhibiting metastasis, the cTME could also represent as a biomarker for predicting patient outcomes and developing strategies for treating cancer.


  • Open Access

    Recurrent Hormone Receptor–Positive Breast Cancer With Multiple Sites of Distant Metastasis: A Case Report and Review of the Literature

    by Lu Li, Hui Liu, Xiangxin Huang, Haojun Luo

    Breast cancer is one of the most common malignancies and the leading cause of cancer‐related mortality among women worldwide, with hormone receptor–positive (HR+) breast cancer being the most common subtype. Current guidelines recommend endocrine therapy as the first‐line treatment for HR+, human epidermal growth factor Receptor 2–negative breast cancer. In this case report, we describe a patient with HR+ breast cancer who developed bone and liver metastases after breast cancer surgery. We document the disease progression from initial treatment to managing local recurrence and treating distant metastasis using salvage chemotherapy combined with endocrine therapy. Importantly, following denosumab treatment, the patient experienced a bone flare; this presented as increased radionuclide uptake on bone scans, but was later confirmed as pseudoprogression. Furthermore, we note changes in the patient’s pathology as the disease progresses.

  • Open Access

    Tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine‐mediated ferroptosis resistance of metastatic cells and T cell dysfunction

    by Yongcan Liu, Shanchun Chen, Xueying Wan, Rui Wang, Haojun Luo, Chao Chang, Peijin Dai, Yubi Gan, Yuetong Guo, Yixuan Hou, et al.

    Background: Tumor metastasis is a major threat to cancer patient survival. The organ‐specific niche plays a pivotal role in tumor organotropic metastasis. Fibroblasts serve as a vital component of the metastatic microenvironment, but how heterogeneous metastasis‐associated fibroblasts (MAFs) promote organotropic metastasis is poorly characterized. Here, we aimed to decipher the heterogeneity of MAFs and elucidate the distinct roles of these fibroblasts in pulmonary metastasis formation in breast cancer. Methods: Mouse models of breast cancer pulmonary metastasis were established using an in vivo selection method of repeated injections of metastatic cells purified from the mouse lung. Single‐cell RNA‐sequencing (scRNA‐seq) was employed to investigate the heterogeneity of MAFs. Transgenic mice were used to examine the contribution of tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts (TDO2 + MFs) in lung metastasis. Results: We uncovered 3 subtypes of MAFs in the lung metastatic microenvironment, and their transcriptome profiles changed dynamically as lung metastasis evolved. As the predominant subtype, MFs were exclusively marked by platelet‐derived growth factor receptor alpha (PDGFRA) and mainly located on the edge of the metastasis, and T cells were enriched around MFs. Notably, high MF signatures were significantly associated with poor survival in breast cancer patients. Lung metastases were markedly diminished, and the suppression of T cells was dramatically attenuated in MF‐depleted experimental metastatic mouse models. We found that TDO2 + MFs controlled pulmonary metastasis by producing kynurenine (KYN), which upregulated ferritin heavy chain 1 (FTH1) level in disseminated tumor cells (DTCs), enabling DTCs to resist ferroptosis. Moreover, TDO2 + MF‐secreted chemokines C‐C motif chemokine ligand 8 (CCL8) and C‐C motif chemokine ligand 11 (CCL11) recruited T cells. TDO2 + MF‐derived KYN induced T cell dysfunction. Conditional knockout of Tdo2 in MFs diminished lung metastasis and enhanced immune activation. Conclusions: Our study reveals crucial roles of TDO2 + MFs in promoting lung metastasis and DTCs’ immune evasion in the metastatic niche. It suggests that targeting the metabolism of lung‐specific stromal cells may be an effective treatment strategy for breast cancer patients with lung metastasis.


  • Open Access

    Supplementary Table S2 from ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis

    by Yuxiang Qiu, Xing Wang, Yan Sun, Ting Jin, Rui Tang, Xinyue Zhou, Ming Xu, Yubi Gan, Rui Wang, Haojun Luo, et al.

    Supplementary Table S2 from ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis

  • Open Access

    Supplementary Table S2 from ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis

    by Yuxiang Qiu, Xing Wang, Yan Sun, Ting Jin, Rui Tang, Xinyue Zhou, Ming Xu, Yubi Gan, Rui Wang, Haojun Luo, et al.

    Supplementary Table S2 from ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis

  • Open Access

    Supplementary Table S1 from ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis

    by Yuxiang Qiu, Xing Wang, Yan Sun, Ting Jin, Rui Tang, Xinyue Zhou, Ming Xu, Yubi Gan, Rui Wang, Haojun Luo, et al.

    Supplementary Table S1 from ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis